by Alexis DUPORT | 8 Jun, 2015 | Gènéthique informs you
The NOICHL resolution proposal was adopted by the European Parliament with a majority of 60 votes, which is rather low compared to the crushing majority that led to the adoption of the Tarabella report on 10 March 2015. This report by the German MP of the...
by Alexis DUPORT | 27 May, 2015 | Gènéthique informs you
As part of the events marking the 20th anniversary of the Jérôme Lejeune Foundation, Jean-Marie Le Méné, its president and Fabrice Hadjaj, philosopher and writer, debated the following topic on 22 May in Neuilly: “What role does the ‘lesser’ human...
by Alexis DUPORT | 25 May, 2015 | Gènéthique informs you
A recent article published in the Science&Santé journal analyses the position of the European Union in terms of human embryo research. This article, which is supplemented by a more in-depth study in the Nature journal, provides an opportunity to readdress embryo...
by Alexis DUPORT | 6 May, 2015 | Gènéthique informs you
ESPERITE, the laboratory that markets the NIPS test, “tranquility”, announced that it “is ready for the mass market”. In a press release dated 30 April 2015, the laboratory confirmed that the test complies with European Directive 98/79/EC relating to medical devices...
by Alexis DUPORT | 14 Apr, 2015 | Gènéthique informs you
EllaOne® (ulipristal acetate) has been marketed in France since May 2009 by the HRA Pharma[1] laboratory. It is indicated in “emergency contraception within 120 hours (5 days) following unprotected sexual intercourse or if a contraceptive method fails”. ...